Clinical trials
Phase 4 trials in Peru
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
71 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 1 |
| 2002 | 2 |
| 2003 | 1 |
| 2004 | 3 |
| 2005 | 2 |
| 2006 | 3 |
| 2007 | 7 |
| 2008 | 3 |
| 2009 | 6 |
| 2010 | 3 |
| 2011 | 9 |
| 2012 | 4 |
| 2013 | 4 |
| 2014 | 8 |
| 2015 | 2 |
| 2016 | 4 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 2 |
| 2021 | 1 |
| 2022 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 64 |
| Unknown status | 3 |
| Active, not recruiting | 2 |
| Terminated | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| GlaxoSmithKline | 8 |
| Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 7 |
| Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | 5 |
| Novartis Pharmaceuticals | 5 |
| Pfizer | 5 |
| Sanofi | 5 |
| Fred Hutchinson Cancer Center | 3 |
| Hoffmann-La Roche | 3 |
| AstraZeneca | 2 |
| Bristol-Myers Squibb | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| HIV Infections | 8 |
| Diabetes Mellitus, Type 2 | 7 |
| Arthritis, Rheumatoid | 4 |
| Asthma | 4 |
| Hypertension | 3 |
| Acquired Immunodeficiency Syndrome | 2 |
| Acromegaly | 2 |
| Acute Pain | 2 |
| Altitude Sickness | 2 |
| Carcinoma, Non-Small-Cell Lung | 2 |
Trials
Showing 51 to 71 of 71. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.